Molecular Templates, Inc. Reviews Second Quarter 2023 Monetary Outcomes and Enterprise Replace
Molecular Templates, Inc. AUSTIN, Texas, Aug. 10, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical firm targeted on the invention and improvement of…